J. Szántó

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

Jean-Marc Nabholtz, Carla I. Falkson, J. Szántó et al. · Journal of Clinical Oncology · 2003 · 383 citations

Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study

Carmelo Pozzo, C. Barone, J. Szántó et al. · Annals of Oncology · 2004 · 157 citations · Full text

Oncology, Esophageal Cancer, Esophageal-gastric Junction Adenocarcinoma +8

The Prevalence of Prostate Carcinoma and Its Precursor in Hungary: An Autopsy Study

Györgyike Soós, Ioannis Tsakiris, J. Szántó et al. · European Urology · 2005 · 125 citations

Urology, Urologic Cancer Epidemiology, Prostate Carcinoma +5

Lateral electron equilibrium and electron contamination in measurements of head‐scatter factors using miniphantoms and brass caps

X. Allen Li, M. Soubra, J. Szántó et al. · Medical Physics · 1995 · 105 citations

Engineering, Electron-beam Lithography, Electron Diffraction +20

A prospective comparison of three systems of patient immobilization for prostate radiotherapy

Shawn Malone, J. Szántó, George Perry et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 70 citations

Adaptive Radiotherapy, Patient Immobilization, Radiation Medicine +10